Fenbenco 444 is supplied as uncoated tablets containing Fenbendazole IP 444 mg in each tablet. The displayed package contains 10 × 10 tablets and carries prescription labeling. Review the directions, warnings, and other information printed on the original product packaging before use.
Each uncoated tablet contains 444 mg of Fenbendazole IP, as stated on the product packaging. The formulation also contains excipients in the quantity required for the tablet.
Fenbenco 444 is presented as an oral tablet formulation. Its packaging states that a physician should direct the dosage.
Do not select a dose, treatment duration, or intended use based solely on information available on an e-commerce website. Follow the original product information and obtain appropriate professional guidance.
Follow the directions provided with Fenbenco 444 and any instructions given by an appropriately qualified healthcare professional.
Do not independently increase the amount used, extend or repeat a course, or use the product for another purpose without appropriate professional advice.
Before using a prescription product, inform an appropriately qualified healthcare professional about relevant health conditions, allergies, and other medicines or healthcare products you are using.
Seek prompt medical attention for an unexpected or serious reaction. Online product information is intended for general reference and should not be relied upon to diagnose a medical condition or establish an individual treatment plan.
The regulatory status and permitted applications of Fenbendazole vary by country, formulation, and product. The ingredient or strength shown on this package should not be interpreted as authorization for every possible use.
This product page does not represent Fenbenco 444 as an FDA-approved medicine for human use in the United States. It also does not claim that Fenbendazole treats cancer or any other unapproved medical condition.
According to the package instructions, protect Fenbenco 444 from light and moisture, and store it at a temperature not exceeding 30°C. Keep the product out of the reach of children and retain the tablets in their original packaging.
The displayed product packaging identifies Astonea Labs Limited as the manufacturer.
This page contains general product information derived from the available packaging. It does not replace professional medical advice, diagnosis, treatment, or official product documentation. Regulatory requirements and authorized uses may differ by country. Review the original package information and obtain appropriate professional guidance before use.